RU96122858A - BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS ON THEIR BASIS - Google Patents
BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS ON THEIR BASISInfo
- Publication number
- RU96122858A RU96122858A RU96122858/04A RU96122858A RU96122858A RU 96122858 A RU96122858 A RU 96122858A RU 96122858/04 A RU96122858/04 A RU 96122858/04A RU 96122858 A RU96122858 A RU 96122858A RU 96122858 A RU96122858 A RU 96122858A
- Authority
- RU
- Russia
- Prior art keywords
- radical
- adamantyl
- benzoic acid
- compound according
- radicals
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 30
- 239000000203 mixture Substances 0.000 title claims 8
- 239000002537 cosmetic Substances 0.000 title claims 3
- -1 Bicyclic aromatic compound Chemical class 0.000 claims 51
- 150000003254 radicals Chemical class 0.000 claims 33
- 125000004432 carbon atoms Chemical group C* 0.000 claims 11
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 9
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical group 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- IVLBGHOBXYPQOA-UHFFFAOYSA-N 1-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]-3-[4-(hydroxymethyl)phenyl]prop-2-yn-1-ol Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(O)C#CC1=CC=C(CO)C=C1 IVLBGHOBXYPQOA-UHFFFAOYSA-N 0.000 claims 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol Chemical group OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 claims 1
- 125000005916 2-methylpentyl group Chemical group 0.000 claims 1
- VVIQDUAONGHZMU-NSCUHMNNSA-N 4-[(E)-2-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]ethenyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1\C=C\C1=CC=C(C(O)=O)C=C1 VVIQDUAONGHZMU-NSCUHMNNSA-N 0.000 claims 1
- BKJHYCKZQGMKMN-RGVLZGJSSA-N 4-[(E)-2-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]prop-1-enyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(\C)=C\C1=CC=C(C(O)=O)C=C1 BKJHYCKZQGMKMN-RGVLZGJSSA-N 0.000 claims 1
- WTNHWHDJZSAGCU-NSCUHMNNSA-N 4-[(E)-2-[4-(1-adamantyl)-3-(3-hydroxypropoxy)phenyl]ethenyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCCCO)=CC=1\C=C\C1=CC=C(C(O)=O)C=C1 WTNHWHDJZSAGCU-NSCUHMNNSA-N 0.000 claims 1
- LPXWUYMQHWLWIG-AATRIKPKSA-N 4-[(E)-2-[4-(1-adamantyl)-3-(6-amino-6-oxohexoxy)phenyl]ethenyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCCCCCC(=O)N)=CC=1\C=C\C1=CC=C(C(O)=O)C=C1 LPXWUYMQHWLWIG-AATRIKPKSA-N 0.000 claims 1
- JOPWQGHIZUOZSC-AATRIKPKSA-N 4-[(E)-2-[4-(1-adamantyl)-3-(6-hydroxyhexoxy)phenyl]ethenyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCCCCCCO)=CC=1\C=C\C1=CC=C(C(O)=O)C=C1 JOPWQGHIZUOZSC-AATRIKPKSA-N 0.000 claims 1
- AXBQORMADCRJGM-BQYQJAHWSA-N 4-[(E)-2-[4-(1-adamantyl)-3-heptoxyphenyl]ethenyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCCCCCCC)=CC=1\C=C\C1=CC=C(C(O)=O)C=C1 AXBQORMADCRJGM-BQYQJAHWSA-N 0.000 claims 1
- MZWYFJVPKZMXCR-OWOJBTEDSA-N 4-[(E)-2-[4-(1-adamantyl)-3-hydroxyphenyl]ethenyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1\C=C\C1=CC=C(C23CC4CC(CC(C4)C2)C3)C(O)=C1 MZWYFJVPKZMXCR-OWOJBTEDSA-N 0.000 claims 1
- KEIPDLXXLZQAMK-NSCUHMNNSA-N 4-[(E)-2-[4-(1-adamantyl)-3-methoxyphenyl]ethenyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OC)=CC=1\C=C\C1=CC=C(C(O)=O)C=C1 KEIPDLXXLZQAMK-NSCUHMNNSA-N 0.000 claims 1
- VQRHXCUQWOMMAO-RQZCQDPDSA-N 4-[(E)-2-[4-(1-adamantyl)-3-methoxyphenyl]prop-1-enyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OC)=CC=1C(\C)=C\C1=CC=C(C(O)=O)C=C1 VQRHXCUQWOMMAO-RQZCQDPDSA-N 0.000 claims 1
- JMIKUHCQYAZTDH-ONEGZZNKSA-N 4-[(E)-2-[4-(1-adamantyl)-3-propoxyphenyl]ethenyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCCC)=CC=1\C=C\C1=CC=C(C(O)=O)C=C1 JMIKUHCQYAZTDH-ONEGZZNKSA-N 0.000 claims 1
- JVNPVTBPKCNDMM-RUDMXATFSA-N 4-[(E)-3-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]-3-oxoprop-1-enyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(=O)\C=C\C1=CC=C(C(O)=O)C=C1 JVNPVTBPKCNDMM-RUDMXATFSA-N 0.000 claims 1
- BKJHYCKZQGMKMN-JAIQZWGSSA-N 4-[(Z)-2-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]prop-1-enyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(\C)=C/C1=CC=C(C(O)=O)C=C1 BKJHYCKZQGMKMN-JAIQZWGSSA-N 0.000 claims 1
- YPWQTAIATVROHU-UHFFFAOYSA-N 4-[2-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]-2-oxoethoxy]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(=O)COC1=CC=C(C(O)=O)C=C1 YPWQTAIATVROHU-UHFFFAOYSA-N 0.000 claims 1
- AYSJLFOVEPYOHA-UHFFFAOYSA-N 4-[2-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]ethynyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C#CC1=CC=C(C(O)=O)C=C1 AYSJLFOVEPYOHA-UHFFFAOYSA-N 0.000 claims 1
- KMHKQAHABHIGTC-UHFFFAOYSA-N 4-[2-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]ethynyl]phenol Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C#CC1=CC=C(O)C=C1 KMHKQAHABHIGTC-UHFFFAOYSA-N 0.000 claims 1
- PNIKXIHXYFQZCJ-UHFFFAOYSA-N 4-[3-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]-3-hydroxyprop-1-ynyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(O)C#CC1=CC=C(C(O)=O)C=C1 PNIKXIHXYFQZCJ-UHFFFAOYSA-N 0.000 claims 1
- MWMHLAUGYBXRRM-UHFFFAOYSA-N 4-[3-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)phenyl]-3-oxoprop-1-ynyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(=O)C#CC1=CC=C(C(O)=O)C=C1 MWMHLAUGYBXRRM-UHFFFAOYSA-N 0.000 claims 1
- VZOPSZNHCBZXLN-UHFFFAOYSA-N 4-[3-[4-(1-adamantyl)-3-methoxyphenyl]-3-hydroxyprop-1-ynyl]-2-hydroxybenzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OC)=CC=1C(O)C#CC1=CC=C(C(O)=O)C(O)=C1 VZOPSZNHCBZXLN-UHFFFAOYSA-N 0.000 claims 1
- IKLLCGASEDIIJX-UHFFFAOYSA-N 4-[3-[4-(1-adamantyl)-3-methoxyphenyl]-3-oxoprop-1-enyl]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OC)=CC=1C(=O)C=CC1=CC=C(C(O)=O)C=C1 IKLLCGASEDIIJX-UHFFFAOYSA-N 0.000 claims 1
- HSKRREDWFPRZOW-UHFFFAOYSA-N 4-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)benzoyl]oxybenzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(=O)OC1=CC=C(C(O)=O)C=C1 HSKRREDWFPRZOW-UHFFFAOYSA-N 0.000 claims 1
- JYWVDRGOZUXLNU-UHFFFAOYSA-N 4-[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)benzoyl]sulfanylbenzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(=O)SC1=CC=C(C(O)=O)C=C1 JYWVDRGOZUXLNU-UHFFFAOYSA-N 0.000 claims 1
- VXCMITXXGBUDON-UHFFFAOYSA-N 4-[4-(1-adamantyl)-3-methoxybenzoyl]oxybenzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OC)=CC=1C(=O)OC1=CC=C(C(O)=O)C=C1 VXCMITXXGBUDON-UHFFFAOYSA-N 0.000 claims 1
- NWLNVQRXYVBOIA-UHFFFAOYSA-N 4-[[4-(1-adamantyl)-3-(2-methoxyethoxymethoxy)benzoyl]amino]benzoic acid Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(=O)NC1=CC=C(C(O)=O)C=C1 NWLNVQRXYVBOIA-UHFFFAOYSA-N 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229960005261 Aspartic Acid Drugs 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- HLCVOBYIVBRKKZ-UHFFFAOYSA-N C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(O)C#CC1=CC=C(C(O)=O)C(O)=C1 Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(O)C#CC1=CC=C(C(O)=O)C(O)=C1 HLCVOBYIVBRKKZ-UHFFFAOYSA-N 0.000 claims 1
- VUWSXQQKKPPBGK-UHFFFAOYSA-N C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(O)C=CC1=CC=C(C(O)=O)C=C1 Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOCCOC)=CC=1C(O)C=CC1=CC=C(C(O)=O)C=C1 VUWSXQQKKPPBGK-UHFFFAOYSA-N 0.000 claims 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical class CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 claims 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 1
- 108010016626 Dipeptides Proteins 0.000 claims 1
- 229940097043 Glucuronic Acid Drugs 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 206010072736 Rheumatic disease Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000000271 cardiovascular Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000003287 optical Effects 0.000 claims 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- ZRSZYZZPBRZMHJ-UHFFFAOYSA-N prop-2-enyl 4-[[4-(1-adamantyl)-3-(1-methoxyethoxymethoxy)benzenecarbothioyl]amino]benzoate Chemical compound C=1C=C(C23CC4CC(CC(C4)C2)C3)C(OCOC(C)OC)=CC=1C(=S)NC1=CC=C(C(=O)OCC=C)C=C1 ZRSZYZZPBRZMHJ-UHFFFAOYSA-N 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000000241 respiratory Effects 0.000 claims 1
- 230000000552 rheumatic Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 claims 1
Claims (27)
в которой R1 обозначает: (I) радикал -CH3, (II) радикал -(CH2)n-O-R4, (III) радикал -O-(CH2)m-(CO)n-R5, (IV) радикал -CO-R6, (V) радикал -CO-O-R7, причем значения m и n, а также значения различных радикалов R4 - R7 приводятся ниже;
R2 обозначает атом водорода или галогена, линейный или разветвленный алкильный радикал с 1-20 атомами углерода, радикал -OR4 или радикал -O-CH2-O-CH2-CH2-O-CH3;
R3 обозначает: (I) радикал -y-(CH2)p-y-(CH2)q-R8; (II) радикал -(CH2)p-(y)s-(CH2)qR8; (III) радикал -y-(CH2)q-R8; (IV) радикал -CH=CH-(CH2)r-R8, причем значения p, q, r и s и радикалов y и R8 приводятся ниже;
X обозначает связи нижеследующих формул (а) - (m), которые могут быть связаны двояким образом:
Ar обозначает радикал, выбираемый среди радикалов следующих формул (a) - (f);
имея в виду, что в вышеуказанном m обозначает целое число, равное 1,2 или 3;
n обозначает целое число, равное 0 или 1;
p обозначает целое число, находящееся в пределах 1-12 включительно;
r обозначает целое число, находящееся в пределах 0-10 включительно;
s обозначает целое число, равное 0 или 1;
t обозначает целое число, равное 0,1 или 2;
y обозначает атом кислорода или радикал s(O)t;
w обозначает атом кислорода, радикал s(O)t или радикал N-R10;
R4 обозначает атом водорода, низший алкильный радикал или радикал -CO-R11;
R5 обозначает низший алкил или гетероцикл;
R6 обозначает атом водорода, низший алкильный радикал или радикал:
в котором R' и R" обозначают атом водорода, низший алкильный радикал, моно- или полигидроксиалкильный радикал, возможно замещенный арильный радикал или остаток аминокислоты или пептида или сахара или, взятые вместе, образуют гетероцикл;
R7 обозначает атом водорода, линейный или разветвленный алкильный радикал с 1-20 атомами углерода, алкенильный радикал, моно- или полигидроксиалкильный радикал, возможно замещенный арильный или аралкильный радикал или остаток сахара или остаток аминокислоты или пептида;
R8 обозначает атом водорода, разветвленный алкильный радикал с 1-20 атомами углерода, циклоалифатический радикал с 3-6 атомами углерода, моногидроксиалкильный радикал или полигидроксиалкильный радикал, гидроксильные группы которого возможно защищены в форме метокси-, ацетокси- или ацетонид-группы, арильный радикал, алкенильный радикал, алкинильный радикал, радикал-СО-R6, радикал -CO-O-R7, аминоалкильный радикал, аминная функция которого возможно замещена одной или двумя алкильными группами; гетероцикл;
R9 обозначает атом водорода или галогена, линейный или разветвленный алкильный радикал с 1-20 атомами углерода, радикал -OR4, радикал -O-CH2-O-CH2-CH2-O-CH3;
R10, одинаковые или различные, обозначают атом водорода, низший алкильный радикал;
R11 обозначает низший алкильный радикал;
причем когда Х обозначает связь формулы (е) и R3 обозначает радикал (III), в котором y представляет атом кислорода и R8 обозначает атом водорода, тогда q должен быть выше б,
а также их соли и их оптические и геометрические изомеры.1. Bicyclic aromatic compound corresponding to the following general formula (I)
in which R 1 means: (I) the radical —CH 3 , (II) the radical is - (CH 2 ) n —OR 4 , (III) the radical —O- (CH 2 ) m - (CO) n —R 5 , ( IV) the radical —CO — R 6 , (V) the radical —CO — OR 7 , the values of m and n, as well as the meanings of the various radicals R 4 - R 7, being given below;
R 2 represents a hydrogen or halogen atom, a linear or branched alkyl radical with 1 to 20 carbon atoms, an —OR 4 radical or a —O — CH 2 —O — CH 2 —CH 2 —O — CH 3 radical;
R 3 means: (I) the radical -y- (CH 2 ) p -y- (CH 2 ) q -R 8 ; (Ii) the radical - (CH 2 ) p - (y) s - (CH 2 ) q R 8 ; (Iii) the radical —y— (CH 2 ) q —R 8 ; (Iv) the radical -CH = CH- (CH 2 ) r -R 8 , with the values p, q, r, and s and the radicals y and R 8 given below;
X denotes the relationship of the following formulas (a) - (m), which can be linked in two ways:
Ar denotes a radical selected among the radicals of the following formulas (a) - (f);
bearing in mind that in the above m is an integer equal to 1.2 or 3;
n is an integer equal to 0 or 1;
p denotes an integer between 1-12 and inclusive;
r is an integer ranging from 0-10 inclusive;
s denotes an integer of 0 or 1;
t is an integer equal to 0.1 or 2;
y represents an oxygen atom or s (O) t radical;
w denotes an oxygen atom, s (O) t radical or NR 10 radical;
R 4 denotes a hydrogen atom, a lower alkyl radical or a radical —CO — R 11 ;
R 5 is lower alkyl or heterocycle;
R 6 denotes a hydrogen atom, a lower alkyl radical or a radical:
wherein R ′ and R ″ represent a hydrogen atom, a lower alkyl radical, a mono- or poly-hydroxyalkyl radical, a possibly substituted aryl radical, or an amino acid or peptide residue, or taken together form a heterocycle;
R 7 denotes a hydrogen atom, a linear or branched alkyl radical with 1-20 carbon atoms, an alkenyl radical, a mono- or polyhydroxyalkyl radical, a possibly substituted aryl or aralkyl radical or a sugar residue or an amino acid or peptide residue;
R 8 denotes a hydrogen atom, a branched alkyl radical with 1-20 carbon atoms, a cycloaliphatic radical with 3-6 carbon atoms, a monohydroxyalkyl radical or a polyhydroxyalkyl radical, whose hydroxyl groups may be protected in the form of a methoxy, acetoxy or acetonide group, aryl radical , alkenyl radical, alkynyl radical, radical CO 2 R 6 , radical —CO — OR 7 , aminoalkyl radical, the amine function of which is possibly substituted by one or two alkyl groups; heterocycle;
R 9 represents a hydrogen or halogen atom, a linear or branched alkyl radical with 1-20 carbon atoms, an —OR 4 radical, a —O — CH 2 —O — CH 2 —CH 2 —O-CH 3 radical;
R 10 , the same or different, represents a hydrogen atom, a lower alkyl radical;
R 11 represents a lower alkyl radical;
moreover, when X denotes a bond of formula (e) and R 3 denotes a radical (III) in which y represents an oxygen atom and R 8 denotes a hydrogen atom, then q must be higher than b,
as well as their salts and their optical and geometric isomers.
4-[4-(1-адамантил)-3-метоксибензоилокси] бензойная кислота; (Е)-4-[[2-[4-(1-адамантил)-3-гидроксифенил]этенил]]бензойная кислота;
(Е)-4-[[2-[4-(1-адамантил)-3-пропилоксифенил]этенил]]бензойная кислота;
(Е)-4-[[2-[4-(1-адамантил)-3-гептилоксифенил]этенил]]бензойная кислота;
(Е)-4-[[2-[4-(1-адамантил)-3-метоксифенил]этенил]]бензойная кислота;
4-[4-(1-адамантил)-3-метоксиэтоксиметоксифенилэтинил]бензойная кислота;
(Е)-4-[[2-[4-(1-адамантил)-3-(5-карбамоилпентилокси)фенил] этенил] ]бензойная кислота;
(Е)-4-[[2-[4-(1-адамантил)-3-метоксифенил] -1-пропенил] ] бензойная кислота;
(Е)-4-[[2-[4-(1-адамантил)-3-(3-гидроксипропилокси)фенил] этенил] ] бензойная кислота;
(Е)-4-[[2-[4-(1-адамантил)-3-(6-гидроксигексилокси)фенил] этенил] ] бензойная кислота;
4-[[3-оксо-3-[4-(1-адамантил)-3-метоксифенил]-1-пропенил]]бензойная кислота;
4-[4-(1-адамантил)-3-метоксиэтоксиметоксибензоилтио]бензойная кислота;
4-[4-(1-адамантил)-3-метоксиэтоксиметоксибензоилокси]бензойная кислота;
4-[4-(1-адамантил)-3-метоксиэтоксиметоксибензамидо]бензойная кислота;
(Е)-4-[2-(4-(1-адамантил)-3-метоксиэтоксиметоксифенил)этенил] бензойная кислота;
(Е)-4-[2-(4-(1-адамантил)-3-метоксиэтоксиметоксифенил)-1-пропенил] бензойная кислота;
(z)-4-[2-(4-(1-адамантил)-3-метоксиэтоксиметоксифенил)-1-пропенил] бензойная кислота;
4-[4-(1-адамантил)-3-метоксиэтоксиметоксибензоилметилокси]бензойная кислота;
4-[[3-оксо-3-[4-(1-адамантил)-3-метоксиэтоксиметоксифенил] -1-пропинил]] бензойная кислота;
4-[[3-гидрокси-3-[4-(1-адамантил)-3-метоксиэтоксиметоксифенил]-пропинил] ]бензойная кислота;
(Е)-4-[[3-оксо-3-[4-(1-адамантил)-3-метоксиэтоксиметоксифенил] -1-пропенил]]бензойная кислота;
4-[[3-гидрокси-3-[4-(1-адамантил)-3-метоксиэтоксиметоксифенил] -1-пропенил] ] бензойная кислота; аллил-4-[4-(1-адамантил)-3-метоксиэтоксиметокситиобензамидо]бензоат;
4-[[3-гидрокси-3-[-(1-адамантил)-3-метоксифенил] -1-пропинил] ]бензойная кислота;
2-гидрокси-4-[[3-гидрокси-3-[4-(1-адамантил)-3-метоксифенил]-1-пропинил] ]бензойная кислота;
2-гидрокси-4-[[3-гидрокси-3-[4-(1-адамантил)-3-метоксиэтоксиметоксифенил]-1-пропинил]]бензойная кислота;
4-[[3-гидрокси-3-[4-(1-адамантил)-3-метоксиэтоксиметоксифенил] -1-пропинил]]бензойная кислота;
4-[[3-гидрокси-3-[4-(1-адамантил)-3-метоксиэтоксиметоксифенил] -1-пропинил]]бензолметанол;
N-этил-4-[4-(1-адамантил)-3-метоксиэтоксиметоксифенилэтинил]бензамид;
N-(4-гидроксифенил)-4-[4-(1-адамантил)-3-метоксиэтоксиметоксифенилэтинил]бензамид;
4-[4-(1-адамантил)-3-метоксиэтоксиметоксифенилэтинил]фенол.19. The compound according to claim 1, characterized in that it is chosen, individually or as a mixture of the following group of compounds:
4- [4- (1-Adamantyl) -3-methoxybenzoyloxy] benzoic acid; (E) -4 - [[2- [4- (1-Adamantyl) -3-hydroxyphenyl] ethenyl]] benzoic acid;
(E) -4 - [[2- [4- (1-Adamantyl) -3-propyloxyphenyl] ethenyl]] benzoic acid;
(E) -4 - [[2- [4- (1-Adamantyl) -3-heptyloxyphenyl] ethenyl]] benzoic acid;
(E) -4 - [[2- [4- (1-Adamantyl) -3-methoxyphenyl] ethenyl]] benzoic acid;
4- [4- (1-Adamantyl) -3-methoxyethoxymethoxyphenylethynyl] benzoic acid;
(E) -4 - [[2- [4- (1-Adamantyl) -3- (5-carbamoylpentyloxy) phenyl] ethenyl]] benzoic acid;
(E) -4 - [[2- [4- (1-Adamantyl) -3-methoxyphenyl] -1-propenyl]] benzoic acid;
(E) -4 - [[2- [4- (1-Adamantyl) -3- (3-hydroxypropyloxy) phenyl] ethenyl]] benzoic acid;
(E) -4 - [[2- [4- (1-Adamantyl) -3- (6-hydroxyhexyloxy) phenyl] ethenyl]] benzoic acid;
4 - [[3-oxo-3- [4- (1-adamantyl) -3-methoxyphenyl] -1-propenyl]] benzoic acid;
4- [4- (1-Adamantyl) -3-methoxyethoxymethoxybenzoylthio] benzoic acid;
4- [4- (1-Adamantyl) -3-methoxyethoxymethoxybenzoyloxy] benzoic acid;
4- [4- (1-Adamantyl) -3-methoxyethoxymethoxybenzamido] benzoic acid;
(E) -4- [2- (4- (1-Adamantyl) -3-methoxyethoxymethoxyphenyl) ethenyl] benzoic acid;
(E) -4- [2- (4- (1-Adamantyl) -3-methoxyethoxymethoxyphenyl) -1-propenyl] benzoic acid;
(z) -4- [2- (4- (1-Adamantyl) -3-methoxyethoxymethoxyphenyl) -1-propenyl] benzoic acid;
4- [4- (1-Adamantyl) -3-methoxyethoxymethoxybenzoylmethyloxy] benzoic acid;
4 - [[3-oxo-3- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenyl] -1-propynyl]] benzoic acid;
4 - [[3-hydroxy-3- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenyl] -propinyl]] benzoic acid;
(E) -4 - [[3-oxo-3- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenyl] -1-propenyl]] benzoic acid;
4 - [[3-hydroxy-3- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenyl] -1-propenyl]] benzoic acid; allyl-4- [4- (1-adamantyl) -3-methoxyethoxymethoxythiobenzamido] benzoate;
4 - [[3-hydroxy-3 - [- (1-adamantyl) -3-methoxyphenyl] -1-propynyl]] benzoic acid;
2-hydroxy-4 - [[3-hydroxy-3- [4- (1-adamantyl) -3-methoxyphenyl] -1-propynyl]] benzoic acid;
2-hydroxy-4 - [[3-hydroxy-3- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenyl] -1-propynyl]] benzoic acid;
4 - [[3-hydroxy-3- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenyl] -1-propynyl]] benzoic acid;
4 - [[3-hydroxy-3- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenyl] -1-propynyl]] benzenemethanol;
N-ethyl-4- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenylethyl] benzamide;
N- (4-hydroxyphenyl) -4- [4- (1-adamantyl) -3-methoxyethoxymethoxyphenylethyl] benzamide;
4- [4- (1-Adamantyl) -3-methoxyethoxymethoxyphenylethynyl] phenol.
-y-(CH2)q-R8; X обозначает связь формулы (a), (h), (i), (j), (k) или (m); Ar обозначает радикал формулы (a) или (b).20. The compound according to claim 1, characterized in that it has at least one of the following characteristics: R 1 denotes the radical-COO-R 7 and -CO-R 6 ; R 3 denotes the radical-y- (CH 2 ) p -y- (CH 2 ) q -R 8 ; - (CH 2 ) p - (y) h - (CH 2 ) q -R 8 ;
-y- (CH 2 ) q -R 8 ; X is a bond of the formula (a), (h), (i), (j), (k) or (m); Ar denotes a radical of formula (a) or (b).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9514261 | 1995-12-01 | ||
FR9514261A FR2741876B1 (en) | 1995-12-01 | 1995-12-01 | BIAROMATIC COMPOUNDS HAVING ADAMANTYL PARA GROUP, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USES THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96122858A true RU96122858A (en) | 1999-02-20 |
RU2134256C1 RU2134256C1 (en) | 1999-08-10 |
Family
ID=9485080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96122858A RU2134256C1 (en) | 1995-12-01 | 1996-11-29 | Aromatic bicyclic compound, pharmaceutical and cosmetic composition |
Country Status (22)
Country | Link |
---|---|
US (1) | US5877342A (en) |
EP (1) | EP0776881B1 (en) |
JP (1) | JP2733054B2 (en) |
KR (1) | KR100236849B1 (en) |
AR (1) | AR004809A1 (en) |
AT (1) | ATE187433T1 (en) |
AU (1) | AU693045B2 (en) |
BR (1) | BR9604631A (en) |
CA (1) | CA2191790C (en) |
DE (1) | DE69605525T2 (en) |
DK (1) | DK0776881T3 (en) |
ES (1) | ES2143734T3 (en) |
FR (1) | FR2741876B1 (en) |
GR (1) | GR3032617T3 (en) |
HU (1) | HUP9603302A3 (en) |
IL (1) | IL119639A0 (en) |
NO (1) | NO307510B1 (en) |
NZ (1) | NZ299788A (en) |
PL (1) | PL185133B1 (en) |
PT (1) | PT776881E (en) |
RU (1) | RU2134256C1 (en) |
ZA (1) | ZA969717B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462064B1 (en) | 1996-07-08 | 2002-10-08 | Galderma Research & Development S.N.C. | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
CZ3499A3 (en) * | 1996-07-08 | 1999-11-17 | Galderma Research & Development, S. N. C. | Adamantyl compound, its use and pharmaceutical composition containing thereof |
FR2757852B1 (en) * | 1996-12-31 | 1999-02-19 | Cird Galderma | STILBENIC COMPOUNDS WITH ADAMANTYL GROUP, COMPOSITIONS CONTAINING SAME, AND USES |
FR2763588B1 (en) * | 1997-05-23 | 1999-07-09 | Cird Galderma | TRIAROMATIC COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES |
ZA994918B (en) | 1998-09-04 | 2000-02-07 | Givaudan Roure Int | New ketones. |
FR2785284B1 (en) * | 1998-11-02 | 2000-12-01 | Galderma Res & Dev | VITAMIN D ANALOGS |
US6436993B1 (en) | 1999-07-13 | 2002-08-20 | The Salk Institute For Biological Studies | Use of RAR antagonists as modulators of hormone mediated processes |
FR2801307B1 (en) | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | VITAMIN D ANALOGS |
FR2825087B1 (en) | 2001-05-22 | 2005-01-14 | Galderma Res & Dev | ANALOGUES OF VITAMIN D |
US7019017B2 (en) * | 2002-05-14 | 2006-03-28 | Baylor College Of Medicine | Small molecule inhibitors of HER2 expression |
US7449480B2 (en) * | 2002-05-14 | 2008-11-11 | Baylor College Of Medicine | Small molecule inhibitors of HER2 expression |
ES2275106T3 (en) | 2002-08-27 | 2007-06-01 | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. | ANALOGS OF VITAMIN D. |
FR2910320B1 (en) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
FR2910321B1 (en) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE |
FR2931661B1 (en) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | NOVEL DEPIGMENTING COMPOSITIONS IN THE FORM OF AN ANHYDROUS VASELIN - FREE AND ELASTOMER - FREE COMPOSITION COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE AND A RETINOID. |
US9181182B2 (en) | 2008-10-17 | 2015-11-10 | Akaal Pharma Pty Ltd | S1P receptors modulators |
NZ592748A (en) | 2008-10-17 | 2013-01-25 | Akaal Pharma Pty Ltd | 2-Amino-(oxadiazol-3-yl)-benzofuran derivatives and their use as S1P receptor modulators |
CN113811300A (en) * | 2019-03-15 | 2021-12-17 | 总医院公司 | Novel small molecule inhibitors of TEAD transcription factor |
WO2021064072A1 (en) | 2019-10-02 | 2021-04-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of retinoic acid receptor (rar) agonists for reversing, preventing, or delaying calcification of aortic valve |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU87821A1 (en) * | 1990-10-12 | 1992-05-25 | Cird Galderma | BI-AROMATIC COMPOUNDS, AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS |
FR2676439B1 (en) * | 1991-05-13 | 1994-10-28 | Cird Galderma | NEW BI-AROMATIC COMPOUNDS DERIVED FROM A SALICYLIC PATTERN, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AS WELL AS IN COSMETICS. |
-
1995
- 1995-12-01 FR FR9514261A patent/FR2741876B1/en not_active Expired - Fee Related
-
1996
- 1996-11-13 DK DK96402423T patent/DK0776881T3/en active
- 1996-11-13 EP EP96402423A patent/EP0776881B1/en not_active Expired - Lifetime
- 1996-11-13 DE DE69605525T patent/DE69605525T2/en not_active Expired - Fee Related
- 1996-11-13 ES ES96402423T patent/ES2143734T3/en not_active Expired - Lifetime
- 1996-11-13 PT PT96402423T patent/PT776881E/en unknown
- 1996-11-13 AT AT96402423T patent/ATE187433T1/en not_active IP Right Cessation
- 1996-11-18 IL IL11963996A patent/IL119639A0/en unknown
- 1996-11-20 AU AU71871/96A patent/AU693045B2/en not_active Ceased
- 1996-11-20 ZA ZA969717A patent/ZA969717B/en unknown
- 1996-11-20 NZ NZ299788A patent/NZ299788A/en unknown
- 1996-11-29 BR BR9604631A patent/BR9604631A/en not_active Application Discontinuation
- 1996-11-29 PL PL96317276A patent/PL185133B1/en not_active IP Right Cessation
- 1996-11-29 JP JP8320452A patent/JP2733054B2/en not_active Expired - Fee Related
- 1996-11-29 AR ARP960105416A patent/AR004809A1/en unknown
- 1996-11-29 HU HU9603302A patent/HUP9603302A3/en unknown
- 1996-11-29 RU RU96122858A patent/RU2134256C1/en not_active IP Right Cessation
- 1996-11-29 NO NO965102A patent/NO307510B1/en not_active IP Right Cessation
- 1996-11-29 KR KR1019960059987A patent/KR100236849B1/en not_active IP Right Cessation
- 1996-11-29 CA CA002191790A patent/CA2191790C/en not_active Expired - Fee Related
- 1996-12-02 US US08/757,638 patent/US5877342A/en not_active Expired - Fee Related
-
2000
- 2000-02-09 GR GR20000400316T patent/GR3032617T3/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU96123243A (en) | BIAROMATIC CONNECTIONS WITH ADAMANTIC GROUP, PHARMACEUTICAL AND COSMETIC COMPOSITIONS ON THEIR BASIS | |
RU96122858A (en) | BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS ON THEIR BASIS | |
RU96108398A (en) | APPLICATION OF RETINOIDS IN COSMETIC OR PHARMACEUTICAL COMPOSITION, COMPOUNDS | |
KR970042511A (en) | Bi-aromatic compounds containing adamantyl groups, pharmaceutical compositions and cosmetic compositions containing the same and uses thereof | |
KR950029244A (en) | Novel Polyene Compounds, Pharmaceutical and Cosmetic Compositions and Uses Containing the Same | |
KR970042508A (en) | Di-aromatic compounds, pharmaceutical compositions and cosmetic compositions containing them, and their uses | |
RU98109793A (en) | TRIAROMATIC COMPOUNDS CONTAINING THEIR COMPOSITIONS AND THEIR APPLICATION | |
RU2003106424A (en) | BIPHENYLIC DERIVATIVES AND THEIR APPLICATION AS ACTIVATORS OF PPARγ RECEPTORS | |
CA2346700A1 (en) | Cysteine derivatives | |
RU99109983A (en) | BIPHENYL DERIVATIVES AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM | |
WO2007148832A1 (en) | Skin whitening agent containing zinc as active ingredient | |
AR003947A1 (en) | USE OF AN EFFECTIVE AMOUNT OF AT LEAST ONE RETINOID TYPE COMPOUND AS AN ACTIVE AGENT IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION, AND SPECIFIC COMPOUNDS OF SUCH TYPE. | |
RU99104819A (en) | BIAROMATIC COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS INCLUDING THEM | |
DE60003021D1 (en) | BENZOIC ACID ESTER DERIVATIVES, THE COMPOSITIONS CONTAINING THEM AND THEIR USE | |
JP2008174453A (en) | Therapeutic agent for scalp alopecia | |
RU2123325C1 (en) | Cosmetic and/or dermatological composition and method for control of internal ageing of skin | |
KR950029242A (en) | Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof | |
CA2545296A1 (en) | Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics | |
JPH11279040A (en) | Composition for external use for skin | |
US5854199A (en) | Cleaning compositions containing acylated dipeptides and acylated amino acids | |
KR100845393B1 (en) | A conditioning shampoo composition | |
JPH0532533A (en) | Cosmetic | |
RU99109984A (en) | BI-AROMATIC COMPOUNDS ASSOCIATED THROUGH HETEROETHINYLENE RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM | |
JP2006022090A (en) | Inflammation inhibitor composed of pyrrolidonecarboxylic acid zinc salt | |
RU2005121907A (en) | NEW COMPOUNDS ARE MODULATORS OF RECIPTORS OF TYPE PPARGAMA AND THEIR APPLICATION IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS |